INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

76,375 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Option exercise
M—
15.9K sh
Jun 11, 2026Jun 15, 2026
Page 820 of 1910
← PrevNext →
traded Jun 11, 2026
+4d
SEC Form 4

Evidence

9
CC
Chen Gerald C.Director
BLNDBlend Labs, Inc.
Option exercise
M—
50.0K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

9
WS
Weingartner StefanDirector
SAROStandardAero, Inc.
Option exercise
M—
6,011 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

9
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Option exercise
M—
23.0K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

9
WH
Woersching Eric H.Director
BLNDBlend Labs, Inc.
Option exercise
M—
50.0K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

9
AO
Arazi Doron OvadiaChief Executive Officer
CRNTCERAGON NETWORKS LTD
Grant or award
A—
133.3K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

9
SA
Shattuck Mayo A IiiDirector
HUTHut 8 Corp.
Grant or award
A—
4,773 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

9
YD
Yu DebraDirector
MGTXMeiraGTx Holdings plc
Grant or award
A—
60.0K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

9
HP
Hill Jesse P.Chief Financial Officer
AGNTAGNT, Inc.
Tax withholding
F$1,542
333 sh
Jun 14, 2026Jun 15, 2026
traded Jun 14, 2026
+1dSEC Form 4

Evidence

9
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Grant or award
A—
4,595 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

9
MB
McGee Sharon D. BoothDirector
TTITETRA TECHNOLOGIES INC
Option exercise
M—
37.7K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

9
AF
Appel Shelley FDirector
MTDRMatador Resources Co
Grant or award
A—
3,642 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

9
MP
McElhinney PaulDirector
SAROStandardAero, Inc.
Option exercise
M—
6,011 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

9
DN
Desai NeilDirector
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
38.0K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

9
RN
Ru NathanielDirector
SGSweetgreen, Inc.
Grant or award
A—
24.1K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

9
FS
Faller Craig S.Director
HIIHUNTINGTON INGALLS INDUSTRIES, INC.
Grant or award
A—
9 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

9
Thomas RagyDirector
CXMSprinklr, Inc.
Grant or award
A—
51.1K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

9
GC
Gallo Ann CDirector
PIPRPIPER SANDLER COMPANIES
Grant or award
A—
20 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

9
ZB
Zhao BaitengDirector
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
38.0K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

8
VL
Villacrez Vicki LDirector, Executive Vice President & CFO
TDSTELEPHONE & DATA SYSTEMS INC /DE/
Option exercise
M—
0 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

8
PH
Perkins Abigail HChief Information Officer
SNEXStoneX Group Inc.
Gift
G—
2,000 sh
Jun 15, 2026Jun 15, 2026
traded Jun 15, 2026
+0dSEC Form 4

Evidence

6
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Grant or award
A—
45.1K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
NW
Newton Charles W.Director
KROSKeros Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$5,522
550 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
SV
Semah VictorChief Legal Officer
HUTHut 8 Corp.
Grant or award
A—
27.2K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
CC
Cowan ChadChief Scientific Officer
IPSCCentury Therapeutics, Inc.
Tax withholding
F$802
358 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
CD
Chewning Eric D.EVP, Maritime Sys & Corp STR
HIIHUNTINGTON INGALLS INDUSTRIES, INC.
Grant or award
A—
10 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

5
HE
Hughes Edmond E. Jr.Ex VP & Chief HR Officer
HIIHUNTINGTON INGALLS INDUSTRIES, INC.
Grant or award
A—
10 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

5
RR
Rickertsen RickDirector
HUTHut 8 Corp.
Option exercise
M—
14.8K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$31K
13.8K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
WM
Wilkinson Amy MarieDirector
HUTHut 8 Corp.
Option exercise
M—
15.7K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
RR
Rickertsen RickDirector
HUTHut 8 Corp.
Grant or award
A—
4,372 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
JM
Jansen John MDirector
OKLOOklo Inc.
Grant or award
A—
3,213 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
WL
Wang LaiPresident, Global Head of R&D
ONCBeOne Medicines Ltd.
Grant or award
A—
229.8K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
RR
Rickertsen RickDirector
HUTHut 8 Corp.
Option exercise
M—
14.8K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
WM
Wilkinson Amy MarieDirector
HUTHut 8 Corp.
Grant or award
A—
4,550 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

5
GJ
Glennan Sean JosephChief Financial Officer
HUTHut 8 Corp.
Grant or award
A—
27.2K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

2
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Grant or award
A—
87.3K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

0
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Derivative conversion · 10b5-1 plan
C—
57.9K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

0
RA
Rohrstock AriehPresident, Gilat Peru
GILTGILAT SATELLITE NETWORKS LTD
Option exercise · 10b5-1 plan
M—
30.0K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

0
CM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$41K
500 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence